Catching Up With Past and Present Beiersdorf Residents of Distinction
Beiersdorf’s Residents of Distinction program mentor and former mentee Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, chats with his mentee Dawn Queen, MD, a Resident at Columbia University Irving Medical Center in New York City, about her experience as one of this year’s five […]
La Roche-Posay Rolls Out New Melasyl-powered Pigment Correctors
Starting with splashy purple-themed debut at IMCAS in Paris and followed by an educational media event in New York City, La Roche-Posay has officially launched MelaB3 Serum & MelaB3 UV. Formulated with Melasyl pigment inhibitor/blocker, L’Oreal’s new multi-patented molecule designed to improve the appearance of dark spots and discoloration, plus 10% niacinamide, MelaB3 Serum reduces a range of skin discoloration on all skin […]
Innovation in Action: Terahertz Biosensor Detects Skin Cancer With “Exceptional” Sensitivity
A new biosensor using terahertz (THz) waves can detect skin cancer with “exceptional” sensitivity, potentially paving the way for earlier and easier diagnoses, according to a study in the IEEE Transactions on Biomedical Engineering. “Traditional methods for detecting skin cancer often involve expensive, time-consuming, CT, PET scans and invasive higher frequencies technologies,” explains study author Shohreh Nourinovin, PhD, […]
FDA Approves Lifileucel, the First Cellular Therapy for Unresectable or Metastatic Melanoma
The U.S Food and Drug Administration (FDA) has approved lifileucel (Amtagvi, Iovance Biotherapeutics Inc) for advanced melanoma. Lifileucel is the first tumor-infiltrating lymphocyte therapy, or TIL, approved for solid tumors. Iovance also announced the pricing of a secondary stock offering, which when combined with the approval, led to a huge stock gain. “The approval of Amtagvi […]
Dr. Suzan Obagi Named First-ever Chief Medical Director at Obagi Cosmeceuticals
Suzan Obagi, MD, is Obagi Cosmeceuticals LLC’s first-ever Chief Medical Director. Obagi is a subsidiary of Waldencast plc. In her role of Chief Medical Director, Dr. Obagi will help shape Obagi’s product development, portfolio refinement, research initiatives, and educational programs. “I am thrilled to be taking on a more formal role at Obagi as the […]
Biofrontera on the Move: Company Raises $16M, Reduces Ameluz Transfer Price
Biofrontera has entered into a securities purchase agreement with healthcare-focused institutional investors led by Rosalind Advisors. The Company raised financing of $8M with an additional $8M tied to milestones for aggregate proceeds of $16M gross priced at market per Nasdaq rules. The stock soared with the announcement, according to media reports. This private placement is […]